Homebuilders have never been busier as they rush to meet the swelling demand. New home sales are spiking with June showing a 55% surge (year-over-year), the largest uptick since the 2005 housing boom.
The global pandemic and ultra-low interest-rates have millennials rushing to the burbs.
Homebuilder stocks have skyrocketed from their March lows. D.R. Horton DHI, the largest homebuilder in the US, is now sitting at its all-time highs. Competitors like PulteGroup PHM, Toll Brother TOL, and KB Home KBH are following suit.
I suspect that this uptick in home sales will continue through the year as the economy recovers. Homebuilder stocks may not be a bad place to buy as these stocks begin to break out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
PulteGroup, Inc. (PHM): Free Stock Analysis Report
Toll Brothers Inc. (TOL): Free Stock Analysis Report
KB Home (KBH): Free Stock Analysis Report
D.R. Horton, Inc. (DHI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.